Intratumor heterogeneity related signature for clinical outcome and immunotherapy advantages in lung adenocarcinoma
Crossref DOI link: https://doi.org/10.1007/s12672-025-02173-3
Published Online: 2025-03-29
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zuo, Yanhua
Lin, Li
Sun, Libo
Text and Data Mining valid from 2025-03-29
Version of Record valid from 2025-03-29
Article History
Received: 7 December 2024
Accepted: 18 March 2025
First Online: 29 March 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.